Boone Capital Management as of Dec. 31, 2023
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 21 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Unum (UNM) | 10.2 | $44M | 962k | 45.22 | |
Colfax Corp (ENOV) | 7.4 | $32M | 563k | 56.02 | |
Amgen (AMGN) | 6.8 | $29M | 102k | 288.02 | |
CVS Caremark Corporation (CVS) | 6.8 | $29M | 367k | 78.96 | |
Globus Med Cl A (GMED) | 6.6 | $28M | 530k | 53.29 | |
Cigna Corp (CI) | 6.3 | $27M | 90k | 299.45 | |
Danaher Corporation (DHR) | 5.9 | $25M | 109k | 231.34 | |
Amphastar Pharmaceuticals (AMPH) | 5.8 | $25M | 400k | 61.85 | |
Molina Healthcare (MOH) | 5.8 | $25M | 68k | 361.31 | |
Baxter International (BAX) | 4.9 | $21M | 549k | 38.66 | |
Viatris (VTRS) | 4.8 | $21M | 1.9M | 10.83 | |
Ideaya Biosciences (IDYA) | 4.4 | $19M | 532k | 35.58 | |
Bridgebio Pharma (BBIO) | 4.2 | $18M | 441k | 40.37 | |
Berry Plastics (BERY) | 3.6 | $16M | 232k | 67.39 | |
Quanterix Ord (QTRX) | 3.6 | $16M | 569k | 27.34 | |
Mirum Pharmaceuticals (MIRM) | 3.4 | $15M | 490k | 29.52 | |
Xenon Pharmaceuticals (XENE) | 2.7 | $12M | 255k | 46.06 | |
Bio Rad Labs Cl A (BIO) | 2.7 | $12M | 36k | 322.89 | |
Orthofix Medical (OFIX) | 1.6 | $6.7M | 500k | 13.48 | |
Mesa Laboratories (MLAB) | 1.6 | $6.7M | 64k | 104.77 | |
Pennant Group (PNTG) | 1.1 | $4.6M | 330k | 13.92 |